| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5622841 | Alzheimer's & Dementia | 2014 | 7 Pages |
Abstract
These data question the previously described role of imatinib in inhibiting amyloidogenic APP processing and as a drug candidate for AD.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Bob Olsson, Laurence Legros, François Guilhot, Kia Strömberg, James Smith, Frederick J. Livesey, David H. Wilson, Henrik Zetterberg, Kaj Blennow,